Loading...

IRWD IRONWOOD PHARMACEUTICALS INC Delisting Actions 8-K Filing

RNWD

RWD

IRONWOOD PHARMACEUTICALS INC

(IRWD)

2025 8-K

Show Summary

Summary

Compliance Regained

Earnings Releases

Dismissal of Independent Re...

Notice of Delisting

Financial Statements

Financial Statements

Strategic Alternatives

Earnings Update

Workforce Reduction

Management Change

Management Change

Earnings Update

Credit Agreement Update

Financial Update

Annual Meeting Voting Results

Appointment, Repayment of C...

Financial Update

Earnings Reports

Press Release and Corporate...

Earnings Reports

Earnings Reports

Completion of Acquisition

Annual Meeting Approval

Acquisition Agreement

Earnings Reports

Departure of Directors or C...

Financial Update

Earnings Reports

External Links:

On May 28, 2025, Ironwood Pharmaceuticals received a notice from Nasdaq stating its stock price had been below the $1.00 minimum requirement for 30 consecutive business days, giving them until November 24, 2025, to comply. The company plans to monitor the stock price and explore options to regain compliance.

AI Assistant

IRONWOOD PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.